Approach Bias Modification didn’t significantly beat standard smoking cessation care, but this may say more about the trial’s power than the intervention itself.
[read the full story...]
Does CBT really outperform other treatments for depression in primary care settings? A recent systematic review suggests patients may have more options than we think.
[read the full story...]
A new RCT tested text message CBT for generalised anxiety in young adults, with promising results. But is it ready for clinical practice?
[read the full story...]
DDD affects around 2% of people but has no approved treatment. A new feasibility trial asks whether CBT-f-DDD could change that.
[read the full story...]
This small trial suggests Psychological Wellbeing Practitioners might deliver focused panic therapy effectively. But with only 46 participants included in the final analysis, larger trials are needed to confirm.
[read the full story...]
British Muslims worry about judgment and misunderstanding in therapy, according to a new qualitative analysis of survey responses. The research shows respect and cultural competence matter more than matching client-therapist faith.
[read the full story...]
Meta-analysis of 13 studies found school-based interventions reduced PTSD, depression and anxiety after natural disasters, with effects strongest immediately post-intervention.
[read the full story...]
This Finnish study of 5,834 healthcare records found therapist-guided internet CBT showed similar depression improvements to face-to-face therapy, providing real-world evidence beyond selective RCT populations.
[read the full story...]
What if therapy focused not on thoughts or voices, but on the vivid images that often accompany them? The iMAPS-2 trial tested a novel imagery-focused therapy for psychosis, showing it’s safe, acceptable, and ready for a full-scale trial.
[read the full story...]
What happens when talking therapies or antidepressants don’t work? This new RCT tested whether mindfulness-based cognitive therapy (MBCT), delivered via Zoom, could help people with hard-to-treat depression, and whether it’s worth the cost. The results will interest NHS decision-makers.
[read the full story...]
